Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-23-001042

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · May 12, 2023 209.9M sh
Operating Cash Flow Q3 2023 · Mar 31, 2023 −$20.54K
Operating Cash Flow Q3 2023 · Mar 31, 2022 −$103.12K
Short Term Debt Q3 2023 · Mar 31, 2023 $733.24K
Short Term Debt Q3 2023 · Jun 30, 2022 $707.7K
Stockholders Equity Q3 2023 · Mar 31, 2023 −$354.33K
Stockholders Equity Q3 2023 · Jun 30, 2022 −$239.13K
Current Liabilities Q3 2023 · Mar 31, 2023 $1.03M
Current Liabilities Q3 2023 · Jun 30, 2022 $935.62K
Total Liabilities Q3 2023 · Mar 31, 2023 $1.1M
Total Liabilities Q3 2023 · Jun 30, 2022 $1.03M
Current Assets Q3 2023 · Mar 31, 2023 $38.71K
Current Assets Q3 2023 · Jun 30, 2022 $67.71K
Total Assets Q3 2023 · Mar 31, 2023 $89.1K
Total Assets Q3 2023 · Jun 30, 2022 $130.79K
Sga Expense Q3 2023 · Mar 31, 2023 $10.18K
Sga Expense Q3 2023 · Mar 31, 2023 $30.62K
Sga Expense Q3 2023 · Mar 31, 2022 $11.92K
Sga Expense Q3 2023 · Mar 31, 2022 $38.39K
Rd Expense Q3 2023 · Mar 31, 2023 $808
Rd Expense Q3 2023 · Mar 31, 2023 $4.81K
Rd Expense Q3 2023 · Mar 31, 2022 $1.98K
Rd Expense Q3 2023 · Mar 31, 2022 $6.48K
Net Income Q3 2023 · Mar 31, 2023 −$38.19K
Net Income Q3 2023 · Mar 31, 2023 −$117.25K
Net Income Q3 2023 · Mar 31, 2022 −$14.86K
Net Income Q3 2023 · Mar 31, 2022 −$51.86K
Operating Income Q3 2023 · Mar 31, 2023 −$22.86K
Operating Income Q3 2023 · Mar 31, 2023 −$66.55K
Operating Income Q3 2023 · Mar 31, 2022 −$28.45K
Operating Income Q3 2023 · Mar 31, 2022 −$91.7K
Gross Profit Q3 2023 · Mar 31, 2023 $18.7K
Gross Profit Q3 2023 · Mar 31, 2023 $70.35K
Gross Profit Q3 2023 · Mar 31, 2022 $17.95K
Gross Profit Q3 2023 · Mar 31, 2022 $58.69K
Revenue Q3 2023 · Mar 31, 2023 $18.7K
Revenue Q3 2023 · Mar 31, 2023 $70.35K
Revenue Q3 2023 · Mar 31, 2022 $17.95K
Revenue Q3 2023 · Mar 31, 2022 $58.69K